OWLT (Owlet, Inc.) Stock Financials & Earnings

OWLTOwlet, Inc.

Mkt Cap$97M

Healthcare·Medical - Devices·🇺🇸 United States·NYSE

Revenue (TTM)$106M

Net Income (TTM)-$38M

EPS (TTM)-$2.14

Free Cash Flow (TTM)-$11M

Gross Margin50.6%

Op. Margin-7.9%

Net Margin-36.3%

FCF Margin-10.8%

P/S Ratio (TTM)0.9x

P/E Ratio (TTM)—

YoY Rev Growth+35.3%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$11M	$4M	-$11M
Q2 23	$13M	$5M	-$7M
Q3 23	$9M	$3M	-$8M
Q4 23	$21M	$10M	-$3M
Q1 24	$15M	$7M	-$6M
Q2 24	$21M	$10M	-$2M
Q3 24	$22M	$12M	-$5M
Q4 24	$21M	$11M	-$7M
Q1 25	$21M	$11M	-$3M
Q2 25	$26M	$13M	-$2M
Q3 25	$32M	$16M	$1M
Q4 25	$27M	$13M	-$5M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$3M	$9M	$3M	—
Q2 23	$3M	$6M	$3M	—
Q3 23	$2M	$5M	$3M	—
Q4 23	$2M	$7M	$4M	—
Q1 24	$2M	$6M	$4M	—
Q2 24	$2M	$6M	$4M	—
Q3 24	$3M	$10M	$4M	—
Q4 24	$3M	$12M	$4M	—
Q1 25	$3M	$7M	$4M	—
Q2 25	$4M	—	—	$12M
Q3 25	$4M	$6M	$5M	—
Q4 25	$4M	$9M	$5M	—

Revenue by Geography

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$25M	$0	$25M
Q2 23	$25M	$0	$25M
Q3 23	$15M	$0	$15M
Q4 23	$17M	$0	$17M
Q1 24	$18M	$0	$18M
Q2 24	$15M	$0	$15M
Q3 24	$22M	$0	$22M
Q4 24	$20M	$0	$20M
Q1 25	$16M	$0	$16M
Q2 25	$22M	$0	$22M
Q3 25	$24M	$0	$24M
Q4 25	$36M	$0	$36M

Shares Outstanding

Revenue Per Employee

Revenue / Employee